Moderna ($MRNA) – What do The Avengers, JFK during the Cuban missile crisis, and Moderna have in common? That's right, they all saved the world. But for Moderna, once wasn't enough. As the Cambridge, MA-based firm begins to tackle diseases ranging from the flu to cancer with its mRNA tech, its stock has been validated enough to earn a spot in the S&P 500, boosting shares 10.3% on Friday.
GX Acquisition Corp. ($GXGX) – Despite the steep drop-off in media coverage, SPACs are still SPACing. Friday's SPACiest newsmaker of all was GX Acquisition, who charged up 27.2% on news of a finalized merger with biotech firm Celularity. Sadly, GX will have to retire their incredibly creative ticker symbol, GXGX, on July 19th to better represent the new combined company, CELU.
Cintas Corp. ($CTAS) – Usually this is where I would introduce a company by telling you what sector they operate in, but for Cintas the story is a little different. The Ohio based Corporation pretty much does anything and everything B2B. They sell things from uniforms and cleaning supplies, all the way to floor mats, safety equipment, and training courses. Talk about a 'jack of all trades'. Regardless of how random the business is, if you're making that guap, Wall Street is happy. With Cintas beating earnings last week, Wall Street said "shut up and take my money", as shares jumped 4.6%.